-
malignancies. Leukemia. 2023;37(4):864-876. Kumar S, Schoonderwoerd MJA, Kroonen JS, et al. Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell
-
particular focus on digital methods and tools. The C²DH's ambition is to venture off the beaten track and find new ways of doing, teaching and presenting contemporary history of Luxembourg and the history
-
protection regulations (e.g. GDPR) Tracking deliverables, reporting progress, and supporting technical documentation and consortium communication Representing the group in consortium meetings, and stakeholder
Searches related to target tracking
Enter an email to receive alerts for target-tracking positions